SpringWorks Therapeutics is a commercial-stage biopharmaceutical company focused on developing and commercializing precision medicine for devastating cancers. The company employs a precision medicine approach to create life-changing medicines that aim to improve the lives of patients with severe cancer conditions. By developing targeted oncology treatments, SpringWorks Therapeutics strives to unlock the full potential of these therapies to extend and improve patients' lives. Their work includes a focus on rare oncology, BCMA combinations in multiple myeloma, and biomarker-defined metastatic solid tumors.